Co-Authors
This is a "connection" page, showing publications co-authored by Vivek R. Nerurkar and Wen-Yang Tsai.
Connection Strength
0.466
-
Tsai WY, Ching LL, Hsieh SC, Melish ME, Nerurkar VR, Wang WK. A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter. Emerg Microbes Infect. 2021 Dec; 10(1):894-904.
Score: 0.214
-
Tsai WY, Hsieh SC, Lai CY, Lin HE, Nerurkar VR, Wang WK. C-terminal helical domains of dengue virus type 4 E protein affect the expression/stability of prM protein and conformation of prM and E proteins. PLoS One. 2012; 7(12):e52600.
Score: 0.115
-
Dai YC, Lin YC, Ching LL, Tsai JJ, Ishikawa K, Tsai WY, Chen JJ, Nerurkar VR, Wang WK. Determining the Time of Booster Dose Based on the Half-Life and Neutralization Titers against SARS-CoV-2 Variants of Concern in Fully Vaccinated Individuals. Microbiol Spectr. 2023 08 17; 11(4):e0408122.
Score: 0.060
-
Tyson J, Tsai WY, Tsai JJ, M?ssg?rd L, Stramer SL, Lehrer AT, Nerurkar VR, Wang WK. A high-throughput and multiplex microsphere immunoassay based on non-structural protein 1 can discriminate three flavivirus infections. PLoS Negl Trop Dis. 2019 08; 13(8):e0007649.
Score: 0.046
-
Hsieh SC, Tsai WY, Nerurkar VR, Wang WK. Characterization of the ectodomain of the envelope protein of dengue virus type 4: expression, membrane association, secretion and particle formation in the absence of precursor membrane protein. PLoS One. 2014; 9(6):e100641.
Score: 0.032